Abstract
Introduction

NF-B transcriptional factors play important roles in regulation of immune and inflammatory responses and protection of cells from apoptosis [1-3]. The mammalian NF-B family has five members: NF-B1 (p105 and p50), NF-B2 (p100 and p52), RelA (p65), RelB and c-Rel, and the most abundant form is the heterodimer of p65
and p50 [1, 3, 4] . In unstimulated cells, they are sequestered in cytosol as inactive homo-or hetero-dimers by binding to IB inhibitory proteins [3, 5] . When cells are exposed to various stimuli, [6, 7] . IKK␤ is the kinase required for the phosphorylation of IB, leading to the polyubiquitination by E3-SCF ␤-trCP ubiquitin ligase complex and subsequent degradation by 26S proteasome [8] . In contrast, IKK␣ is not required for the IB␣ degradation but is involved in the processing of p100 to p52 [9] . These effects induce translocation and activation of NF-B in the nucleus and activate the transcription of genes related to inflammation and immune responses, cell growth, differentiation, apoptosis and transformation [10, 11] . p53 tumour suppressor stands at the crossroads of cellular responses to various stresses [12] . Under normal conditions, p53 is maintained at low level through its interaction with MDM2 [13, 14] , which mediates ubiquitination and proteasome-dependent degradation of p53. However, in response to DNA damage, both the [15] . p53 accumulation and activation are thought to be regulated through posttranslational modifications such as phosphorylation, acetylation and ubiquitination. Phosphorylation of p53 usually modulates its stability and sequence-specific DNA-binding activity [12] . For instance, phosphorylation of Ser15, Thr18, Ser20 and Ser37 stabilizes p53 by disrupting interaction between p53 and MDM2 [16] , whereas phosphorylations at the p53 C-terminus such as Ser315 and Ser392 are reported to regulate the oligomerization state and sequence-specific DNA-binding ability of p53 [17] .
IB is rapidly phosphorylated by a large cytoplasmic IB kinase (IKK) complex, which consists of the kinase catalytic sub-units IKK␣ and IKK␤ (also known as IKK1 and IKK2) and the essential regulatory sub-unit IKK␥ (also known as NEMO)
Acquisition of resistance to chemotherapeutic agents has emerged as a significant impediment to effectively treat cancers. Some of the cytotoxicity of chemotherapy is attributed to apoptosis through activation of tumour-suppressor protein p53 [18] . The [21] . and CYL-26z were synthesized [20] and dissolved as stock solution (50 mM) in dimethyl sulfoxide (DMSO). [21] . 
MTT assay
In vitro invasion assay
Semi-quantitative RT-PCR assay
Chromatin immunoprecipitation assay (ChIP)
ChIP analysis was performed as described previously [22] . 
Statistical analysis
Data were analyzed using Student's t-test. P-values Ͻ0.05 were considered significant. [23] .
Results
Cell proliferation, tumour formation, invasion, metastasis and angiogenesis induced by A549/IKK␤(WT), A549/IKK␤(AA) and A549/IKK␤(FF) alveolar epithelial cells
IKK␤ plays a major role in the activation of classical NF-B pathway. It has been well established that IKK␤ activation requires phosphorylation of Ser177 and Ser181 in its activation loop
In addition to these sites, phosphorylation of IKK␤ at Tyr188 and Tyr199 were also identified to be crucial for NF-B activation [24, 25] . 
anti-tumour properties of CYL-19s and CYL-26z were further confirmed by MTT assay. CYL-19s and CYL-26z markedly inhibited the cell growth in a dose-dependent manner. The respective growth inhibition was 20, 24, 64, 83 and 84% induced by 1, 3, 10, 30 and 50 M of CYL-19s. An equivalent effect was seen by CYL26z (Fig. 2D). Altogether, these findings revealed that inhibition of IKK␤ by CYL-19s and CYL-26z exhibit anti-tumour activity via induction of cell cycle arrest at both G1 and G2/M phase, inhibition of DNA synthesis and initiation of apoptosis.
IKK␤ inhibitors increased the level of p21
To characterize which gene related to cell cycle and apoptosis was regulated by CYL-19s and CYL-26z, RPA was performed. As shown in Fig. 3A , CYL-19s and CYL-26z induced p21, Bax and DR5 mRNA expression but had no effect on p53 mRNA expression. We also analyzed the mRNA levels of pro-apoptotic Bcl-2 family genes, Noxa and Puma, which are reported to be p53 target genes [28] . (Fig. 4B) . Knockdown of IKK␤ by siRNA also increased p21 promoter activity (Fig. 4C) 
Their expression was not induced by the treatment with 5 M CYL-19s and CYL-26z (Fig. 3B). The increase in p21 protein expression was confirmed by Western blot. The expression of p21 was enhanced by CYL-19s or CYL-26z in a dose-and time-dependent manner (Fig. 3C-E). p21 is a well-known target of p53. To determine whether p53 is responsible for the CYL-19s-and CYL-26z-induced p21 expression, p21 constructs (illustrated as Fig. 4A) were transiently transfected into A549 cells. Both CYL-19s-and CYL-26z induced the p21 promoter activity by about 2.5-fold, and these effects were abolished once p53-responsive element 1 (p53RE1) on p21 promoter was deleted
, demonstrating that loss of IKK␤ induced p21 expression. To confirm the role of p53 in CYL compoundinduced p21 expression, the p21 protein level was further examined in CYL compound-treated HCT116 wild-type (wt) and p53
-/-cells.
CYL-19s and CYL-26z can induce p21 expression in HCT116 wt cells, but the effect was not observed in HCT116 p53 -/-cells (Fig. 4D), confirming the induction of p21 expression through a p53-dependent
Fig. 3 IKK␤ inhibitors stimulate p21 expression in A549 epithelial cells. (A) RNase-protected probes hybridized with total RNA from A549 cells treated with 5 M CYL-19s and CYL-26z for 24 hrs were subjected to RNase protection assay (RPA) as described in Materials and Methods, GADPH and L32 were shown as internal controls. (B) Cells were treated with 5 M CYL-19s and CYL-26z for 24 and 48 hrs, and then mRNA were prepared and subjected to RT-PCR. For p21 protein expression, cells were treated with indicated concentration of CYL-19s and CYL-26z for 24 hrs (C), or with 10 M CYL19s and CYL-26z for indicated time (D and E).
Whole-cell lysates were subjected to immunoblotting using antibody specific for p21 or actin. Fig. 4E (Fig. 3A) , it is suggested that inhibition of IKK␤ may increase p53 expression at post-translational level. (Fig. 5B) . Furthermore, the promoter activity using a p53-responsive promoter-luciferase plasmid (p53-Luc) was also activated by CYL-19s and CYL-26z (Fig. 5C) 
pathway. p53 transactivation is correlated with its DNA-binding activity, therefore, effect of CYL-19s and CYL-26z on the recruitment of p53 to p21 promoter was examined by chromatin immunoprecipitation (ChIP) assay. As shown in
IKK␤ inhibitors increased the stability and activity of p53
To further confirm the level of p53 transcript was not affected in the presence of CYL-19s and CYL-26z, a semi-quantitative RT-PCR assay was performed to examine the p53 mRNA in A549 cells. In consistence with the result from RPA, the level of p53 mRNA was not significantly affected in both CYL-19s-and CYL26z-treated A549 cells (Fig. 5A). However, an increase in protein expression of p53 indeed was seen in response to CYL-19s and CYL-26z stimulation after a 4-hr treatment and sustained for 24 hrs
CYL-19s and CYL-26z. Whole-cell lysates were examined by anti-p21 or anti-p53 antibody. (E) A549 cells were treated with 10 M CYL-19s and CYL-26z for the indicated times, and then ChIP assays were performed. Chromatin was immunoprecipitated with anti-p53 antibody or without antibody (control). One percent of the precipitated chromatin was assayed to verify equal loading (Input). Five-fold dilution was subjected to PCR using primer to the p21 promoter (-2312/-2131 and -1490/-1279).
( Fig. 6B) . Thus, CYL-19s and CYL-26z-mediated p53 activation resulted from the decrease in its degradation. The accumulation of p53 in the nucleus was also seen using an immunofluorescence assay (Fig. 6C) . Post-translational modification of p53 such as phosphorylation and acetylation at the C-terminal is closely related to its stabilization and transcriptional activation [29] . Our data also showed that the acetylation of p53 on Lys373/382 in either the nucleus or total cell lysates (TCL) was seen upon CYL-19s and CYL-26z stimulation (Fig. 6D) , suggesting that inhibition of IKK␤ may increase p53 protein stability through these post-translational modification. Fig. 7A and B) . [30] . The association of NF-B activation with tumour promotion, progression and metastasis is well documented in several mouse models [31, 32] [24, 25] . Here, we demonstrated that mutation of Ser177/Ser181 to AA and Tyr188/Tyr199 to FF showed similar effect to abrogate tumour promotion (Fig. 1) [34] . For example, quinacrine, an anti-malarial drug, and other derivatives of 9-aminoacridine are found to simultaneously repress NF-B and activate p53 in renal cell carcinoma [35] . In the present study, IKK␤ inhibitors (Fig. 3A) . They also induced IKK␤ has been reported to increase the levels of MDM2, thereby negatively regulating p53 stability [19] . Bcl-3, a member of IB family, is shown to interact with NF-B p50 and p52 homodimers to promote the transcriptional activity of NF-B [38, 39] . Similar to IKK␤, Bcl-3 is also shown to induce MDM2 gene expression and the subsequent suppression of p53 activity [40] . It is possible that loss of IKK␤ negatively regulated MDM2 and then stabilized p53 expression [19] . However, a number of reports showed the increase of p53 transcription and stability by activated NF-B, which can induce the expression of p53 via B sites in its promoter [41] [42] [43] [44] . Therefore, it needs to be investigated why loss or activation of NF-B can increase p53 stability. It has been proposed that basal NF-B activity is important for cell survival under normal conditions. However, in the presence of DNA damage, NF-B stabilizes p53 and therefore serves an acute pro-apoptotic function [45, 46] . Indeed, NF-B has been reported to exert both pro-apoptotic and anti-apoptotic activities [47] .
IKK␤ inhibitors exhibit p53-dependent anti-tumour activity
However, the decreased cell viability in p21 -/-cells was not recovered (Fig. 7A), because CYL compounds accumulated more cells at subG1 (CYL-19s-treated cells; 16.9-29.6%) or G2/M phase (CYL-26z-treated cells; 34.2-56.4%) (Fig. 7B). These findings revealed that the anti-tumour activity of CYL-19s and CYL-26z acts via p53-dependent but p21-independent apoptosis.
Discussion
NF-B is a major link between inflammation and cancers
Diverse stresses activate p53 by post-translational modifications and nuclear accumulation, contributing to the apoptotic activity of p53 in several cancer cells. Among post-translational modifications, ubiquitination, phosphorylation and acetylation mostly affect its overall appearance and activity [12] . Recent findings suggest that these modifications have a profound effect on p53 stability and function. Phosphorylation of Ser392 stabilizes the formation of p53 tetramer, which is critical for enhancement of DNA binding and activating gene transcription [48, 49] . Phosphorylation of p53 on serines 15 and 20 at the N-terminus and acetylation on lysines 373 and 382 at the C-terminus attenuate its interaction with MDM2, which possesses E3 ligase activity to induce p53 ubiquitination and degradation [29] . Moreover, p53 acetylation stimulates its DNA-binding activity in vivo and promotes apoptosis [50] of IKK␤ (Fig. 5D) 
